NYSE
Bio-Rad Laboratories, Inc. Class A (BIO)
♥ 341 Thanks from members
Bio-Rad Laboratories (BIO) exhibits a mixed financial profile, balancing strong Q2 GAAP net income driven by its Sartorius AG investment and digital PCR momentum against flat currency-neutral revenue guidance and macro-driven Life Science segment declines.